Trump names ex-pharma executive and U.S. Army general to lead vaccine campaign

Editado por Ed Newman
2020-05-18 17:02:42

Pinterest
Telegram
Linkedin
WhatsApp

Washington, May 18 (RHC)-- U.S. President Donald Trump has named Moncef Slaoui, a former executive at pGlaxoSmithKline, and Army General Gustave Perna to lead the effort to develop a coronavirus vaccine, which Trump has dubbed “Operation Warp Speed.” 

Some observers have raised a red flag over a possible conflict of interest as Slaoui holds $10 million in stock options at biotech company Moderna, Inc., which recently received $480 million in federal funding for coronavirus vaccine trials.
 



Comentários


Deixe um comentário
Todos os campos são requeridos
Não será publicado
captcha challenge
up